Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

23.02 -0.46 (-1.96%)
Official Closing Price Updated: 7:00 PM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
49 50 Next >
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
HIMS Q1 Earnings Call: Personalized Care and New Partnerships Drive Upside, Guidance Signals Near-Term Transition
Telehealth company Hims & Hers Health (NYSE:HIMS) announced better-than-expected revenue in Q1 CY2025, with sales up 111% year on year to $586 million. Revenue guidance for the full year exceeded... 
Via StockStory
News headline image
Hims & Hers Stock Rises on Fundamentals and Squeeze Potential
Hims & Hers stock is now giving investors another reason to consider it a buy for the coming months, as the latest quarterly earnings show momentum. 
Via MarketBeat
News headline image
What's Going On With Hims & Hers Stock Tuesday? ↗
Hims & Hers stock was trading lower but has since reversed and began trading higher after the company reported first-quarter earnings on Monday after the market closed. 
Via Benzinga
News headline image
Earnings Scheduled For May 5, 2025 ↗
 
Via Benzinga
News headline image
Looking At Hims & Hers Health's Recent Unusual Options Activity ↗
 
Via Benzinga
News headline image
FARO Technologies, Celanese, Avient, Aramark And Other Big Stocks Moving Higher On Tuesday ↗
 
Via Benzinga
News headline image
Top 1% Stock, Hims & Hers Health, Dives On Lackluster Outlook ↗
The company recently inked a deal with Novo Nordisk. But will that bolster current-quarter sales? 
Via Investor's Business Daily
News headline image
Hims & Hers Stock Slides Pre-Market As Q2 Sales View Misses Estimates, But Retail Traders Shrug It Off ↗
Its second-quarter revenue guidance of $530 million-$550 million fell short of the $564.57 million consensus estimate. 
Via Stocktwits
Topics Earnings
News headline image
Hims & Hers Health’s (NYSE:HIMS) Q1: Beats On Revenue, Full-Year Outlook Slightly Exceeds Expectations
Telehealth company Hims & Hers Health (NYSE:HIMS) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 111% year on year to $586 million. Revenue guidance for the full... 
Via StockStory
News headline image
Hims & Hers Health Q1 Earnings: Revenue Jumps 111%, Subscribers Up 38%, Q2 Guidance Falls Short Of Estimates, Shares Slide ↗
Hims & Hers Health reports first-quarter revenue of $586.01 million, beating estimates of $538.2 million, according to Benzinga. 
Via Benzinga
News headline image
Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results
From Hims & Hers
Via Business Wire
News headline image
ETFs Last Week: Tech-Fueled Rally Powers Gains During Trade Optimism ↗
Wall Street rebounds from tariff losses, with S&P 500 recording second consecutive weekly gain. Top performers were tech giants and leveraged ETFs. 
Via Benzinga
Topics ETFs Stocks World Trade
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Hims & Hers Names New COO. Stock Rallies. ↗
Hims stock rose Monday after the telehealth program named technology industry veteran Nader Kabbani as its new chief operating officer. 
Via Investor's Business Daily
Topics Government Stocks World Trade
News headline image
Hims & Hers Appoints Ex-Amazon Exec Ahead Of Q1 Results ↗
Hims & Hers Health shares are trading marginally lower Monday morning. The company earlier appointed Nader Kabbani as its new Chief Operations Officer, ahead of Q1 results. 
Via Benzinga
News headline image
Hims & Hers: The Next Amazon? Novo Nordisk Might Be Prime Delivery ↗
Hims & Hers Health Inc. (NYSE:HIMS) partners with Novo Nordisk to offer affordable weight-loss drug, positioning itself to expand into other healthcare areas. 
Via Benzinga
News headline image
Hims & Hers Appoints Amazon Veteran Nader Kabbani COO To Support Expansion ↗
A nearly 20-year Amazon veteran, Nader Kabbani said he was drawn to Hims & Hers by its potential to expand access to fast, reliable, and high-quality care. 
Via Stocktwits
Topics Artificial Intelligence Economy Government
News headline image
Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer
From Hims & Hers
Via Business Wire
News headline image
Pony AI, Hims & Hers And Frontdoor Are Among Top 11 Mid-Cap Gainers Last Week (Apr 28-May 2): Are The Others In Your Portfolio? ↗
Top performers last week: PONY, HIMS, ODD, MTSR, CGON, KNSA, KC, FTDR, ATI, PRDO, and IRTC. Have you invested in them? 
Via Benzinga
Topics Artificial Intelligence
News headline image
Hims & Hers Health Earnings: What To Look For From HIMS
Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting results tomorrow after the bell. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence
News headline image
Why Is Novo Nordisk Stock Trading Higher On Friday? ↗
Health Canada begins a priority review of semaglutide 2.4 mg, a weekly treatment by Novo Nordisk for MASH, a liver disease affecting patients with obesity. 
Via Benzinga
News headline image
Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday ↗
GLP-1 drug prices are falling. That's good news for patients, but perhaps not such good news for pharmaceutical stock investors. 
Via The Motley Fool
Topics World Trade
News headline image
CVS Caremark To Place Novo Nordisk's Wegovy On Preferred Coverage For GLP-1 Weight Loss Treatment ↗
Wegovy to become preferred GLP-1 drug on CVS Caremark's top formularies in 2025 as Novo Nordisk expands patient access initiatives. 
Via Benzinga
News headline image
Where Is Hims & Hers Stock Headed After Wegovy Tie-Up? Retail Traders Bet On Rebound To Over 2-Month High ↗
Needham called the tie-up a “groundbreaking partnership” and said it alleviates investor concerns around Hims’ ability to hit its 2025 weight loss revenue guidance. 
Via Stocktwits
News headline image
Hims & Hers Stock Soars on Novo Nordisk Collaboration
Hims & Hers stock rallies by over 25% on news of a collaboration with Novo Nordisk and its weight loss flagship products, and that's not all. 
Via MarketBeat
News headline image
Most active stocks in Tuesday's session ↗
Discover the most active stocks in Tuesday's session. Stay informed about the stocks that are generating the most trading volume! 
Via Chartmill
News headline image
Why Hims & Hers Health and LifeMD Are Skyrocketing Today ↗
Via The Motley Fool
Topics Stocks
News headline image
Hims & Hers Health (HIMS) Shares Skyrocket, What You Need To Know
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 34.9% in the pre-market session after Novo Nordisk announced plans to offer its weight loss drug Wegovy through the company's (Hims &... 
Via StockStory
Topics Economy Government World Trade
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
49 50 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.